Global Influenza Diagnostics Market, by Test Type (Traditional Diagnostic Test and Molecular Diagnostic Assays), by End User (Hospitals and Clinics, Reference Laboratories, and Others), and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018- 2026

Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/2414

Influenza (flu) is a contagious disease of the upper respiratory system caused due to influenza virus. The two types of influenza are seasonal and pandemic. There are three main types of seasonal influenza, namely influenza A, B, and C. It is transmitted from public places through sneeze and droplets of infected person who serve as a carrier of the disease. According to the Centers for Disease Control and Prevention (CDC), in U.S. Influenza resulted in 49,000,000 symptomatic illnesses and 79,000 deaths in 2017-2018. High risk of influenza infection is observed in pregnant women, pediatrics, geriatrics, patients with low immunity that suffer from chronic illness, and healthcare professionals.

Influenza Diagnostic Market – Dynamics

High prevalence of influenza and increasing research funding for influenza diagnostics are major factors that are expected to drive the market growth over the forecast period. According to the World Health Organization (WHO), influenza is expected to result in around 3 to 5 million cases of severe illness and around 290,000 to 650,000 deaths in 2018 worldwide. In 2014, National Institute of Allergy and Infectious Disease (NIAID) collaborated with The National Institutes of Health (NIH) Autoimmune Disease Coordinating Committee (ADCC) and supports The Center of Excellence in Influenza Research and Surveillance (CIERS) to advance the understanding of influenza virus. High geriatric population prone to influenza, increasing awareness about the disease along with high demand for advanced and more efficient influenza diagnostic tests are expected to drive growth of the influenza diagnostics market.

Influenza Diagnostic Market – Regional insights

North America accounted for the largest market share in the global influenza diagnostics market. This is owing to robust initiatives of CDC toward controlling the spread of the disease by actively implementing preventive measures and recognizing the disease through its National Influenza Surveillance System. Increasing availability of Rapid Diagnostic Tests (RDTs) in the U.S. has further boosted these implementations.

Asia Pacific is expected to witness rapid growth in the market during the forecast period, owing to actively participation of countries for preventive measures to counter the incidence of the influenza. For instance, in 2014 CDC funds nine non-researched-related bilateral influenza cooperative agreement in South-East Asian Region (SEAR), as a measure to respond to avian, seasonal, and pandemic influenza.

Influenza Diagnostic Market – Competitive landscape

Major players operating in the global influenza diagnostic market include, Roche Diagnostics, Becton, Dickinson and Company, Thermo Fisher Scientific, Alere, Quidel Corporation, and others. Key players in the market are focused on research and development activities in order to offer diagnostic devices that are cost-effective and efficient. For instance, in 2016, Roche received the U.S. FDA clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver for its cobas Influenza A/B & RSV test. The test is used with the cobas Liat system and assists in molecular testing of flu A/B and RSV.

Browse Complete Report For More Information @ https://www.coherentmarketinsights.com/ongoing-insight/influenza-diagnostics-market-2414

Influenza Diagnostic Market Taxonomy:

On the basis of test type, the global influenza diagnostic market is segmented into:
Traditional Diagnostic Tests

Rapid Influenza Diagnostic Tests (RIDT) ,Viral Culture ,Direct Fluorescent Antibody (DFA) Tests ,Serological Assays

Molecular Diagnostic Assays

RT-PCR ,Nucleic Acid Sequence-Based Amplification (NASBA) Tests ,Loop-Mediated Isothermal Amplification-Based Assays (LAMP) ,Simple Amplification-Based Assays (SAMBA) ,Others


On the basis of end user, the global influenza diagnostic market is segmented into:
Hospitals & Clinics ,Reference Laboratories ,Others


About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.


Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]